Eckert & Ziegler Annual Financial Statement 2017: Profit and net liquidity reach new records, sales stable
Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in in isotope-related ap…
Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in in isotope-related ap…
Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700)…
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a Berlin-based company specializing in isotope tec…
Eckert & Ziegler AG, a specialist for isotope-based applications in medicine, science and industry, finished fiscal year…
As part of the restructuring measures at medical technology company Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZB…
Eckert & Ziegler has received market clearance from the U.S. Food and Drug Administration (FDA) for its new SagiNova® af…
The company Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) increased its sales by 9 % to € 127 mil…
OctreoPharm Sciences GmbH, in which Eckert & Ziegler Radiopharma GmbH holds an interest, has received the coveted and fi…
For the first time, a system designed to provide radiation in treating gynecological tumors with brachytherapy sources h…
OctreoPharm Sciences GmbH, a development company for radiopharmaceuticals, treated its first patients in a Swiss univer…